Preoperative radiochemotherapy of advanced resectable cancer of the oral cavity with cisplatin vs paclitaxel/carboplatin. Analysis of two multimodality treatment concepts;Präoperative Radio-Chemotherapie fortgeschrittener, resektabler Mundhöhlen-karzinome mit Cisplatin vs. Paclitaxel/Carboplatin. Analyze zweier multimodaler Therapiekonzepte

Mund - Kiefer - und Gesichtschirurgie

Volumn 10, Issue 1, 2006, Pages 30-36

  Eckardt, Andre ^a   Wegener, G ^a   Karstens, J H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cisplatin based treatment regimen; Head and neck tumors; Local tumor control; Overall survival; Taxane

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; PACLITAXEL;

ADJUVANT THERAPY; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; MORTALITY; MOUTH TUMOR; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; OROPHARYNX TUMOR; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA; SURVIVAL;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; CISPLATIN; CLINICAL TRIALS, PHASE II; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MULTICENTER STUDIES; NEOADJUVANT THERAPY; OROPHARYNGEAL NEOPLASMS; PACLITAXEL; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS;

EID: 31144466038     PISSN: 14329417     EISSN: 14343940     Source Type: Journal    
DOI: 10.1007/s10006-005-0659-8     Document Type: Article

References (30)

1. Adelstein DJ, Lavertu P, Saxton JP et al. (2000) Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer 88: 876-883 10.1002/ (SICI)1097-0142(20000215)88:4<876::AID-CNCR19>3.0.CO;2-Y
2. Chougule P, Wanebo H, Akhtar M et al. (1998) Concurrent paclitaxel, carboplatin and radiotherapy in advanced head and neck cancers: A phase II study. Proc Am Soc Clin Oncol 17: Abstr 1468
3. Choy H, Browne MJ (1995) Paclitaxel as radiation sensitizer in non-small-cell lung cancer. Semin Oncol 22 (Suppl 6): 70-74
4. Cohen EEW, Lingen MW, Vokes EE (2004) The expanding role of systemic therapy in head and neck cancer. J Clin Oncol 22: 1743-1752 10.1200/ JCO.2004.06.147
5. Cooper JS, Pajak TF, Forastiere AA et al. (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350:1937-1944 10.1056/ NEJMoa032646
6. Cox DR (1972) Regression models and life tables. J R Stat Soc 34: 187-220
7. DÖSAK (1982) Definition zum radikalchirurgischen Vorgehen bei Plattenepithelkarzinomen der Mundhöhle. Mund Kiefer GesichtsChir 6: 369-372
8. Dunphy F, Boyd J, Varvares M et al. (1996) Phase I trial of preoperative (PRE) chemotherapy using paclitaxel/paraplatin in head and neck carcinoma (HNCA). Proc Am Soc Clin Oncol: Abstr 892
9. Eckardt A, Küttner C, Wildfang I, Rades D, Karstens JH (1999) A phase II evaluation of preoperative concurrent paclitaxel, carboplatin and radiotherapy in stage III/IV operable cancer of the oropharynx and oral cavity: 1-year-results. J Cancer Res Clin Oncol 125(S2): S119
10. Eckardt A, Wildfang I, Rades D, Kuettner C, Dammer R, Hofele C, Karstens JH (2000) Multicenter phase II study of preoperative concurrent paclitaxel, carboplatin and radiotherapy in stage III/IV resectable cancer of the oropharynx and oral cavity: An interim analysis. Proc Am Soc Clin Oncol 19: 420
11. Eckardt A, Rades D, Rudat V et al. (2002) Prospektive Phase-II-Studie zur neoadjuvanten Radio-Chemo-Therapie fortgeschrittener, operabler Mundhöhlenkarzinome: 3-Jahres-Ergebnisse. Mund Kiefer GesichtsChir 6: 117-121 10.1007/s10006-002-0370-y
12. Elomaa L, Joensuu H, Kulmala J, Klemi P, Grenman R (1995) Squamous cell carcinoma is highly sensitive to Taxol ®, a possible new radiation sensitizer. Acta Otolaryngol (Stockh): 340-344
13. Flood WA, Lee DJ, Trotti A et al. (1996) A phase I study of weekly paclitaxel and cisplatin concurrent with postoperative radiation therapy for treatment of high risk patients with squamous cell cancer of the head and neck. Proc Am Soc Clin Oncol 15: Abstr 134
14. Forastiere AA (1994) Paclitaxel (Taxol) for the treatment of head and neck cancer. Semin Oncol 21: 49-52
15. Hoffmann W, Heinrich V, Belka C et al. (1996) Präklinische und klinische Ergebnisse in der simultanen Radio-Chemo-Therapie von Kopf-Hals-Tumoren mit Paclitaxel. Strahlenther Onkol 172 (Suppl I): 15-20 8633268
16. Hoffmann W, Belka C, Schmidberger H et al. (1997) Radiotherapy and concomitant weekly 1-hour infusion of paclitaxel in treatment of head and neck cancer - results from a phase I trial. Int J Radiat Oncol Biol Phys 37: 691-696 10.1016/S0360-3016(97)00116-8
17. Kirita T, Ohgi K, Shimooka H et al. (1999) Preoperative concurrent chemoradiotherapy plus radical surgery for advanced squamous cell carcinoma of the oral cavity: An analysis of long-term results. Oral Oncol 35: 597-606 10.1016/S1368-8375(99)00044-5
18. Liebmannn J, Cook JA, Fisher J, Teague D, Mitchell JB (1994) In vitro studies of Taxol as a radiation sensitizer in human tumor cells. J Natl Cancer Inst 86: 441-446 7907149
19. Milas L, Mason KA, Liao Z, Ang KK (2003) Chemoradiotherapy: Emerging treatment improvement strategies. Head Neck 25: 152-167 10.1002/hed.10232
20. Mohr C, Bohndorf W, Karstens J et al. (1994) Präoperative Radio-Chemotherapie versus alleinige Radikaloperation fortgeschrittener Mundhöhlenkarzinome. 3-Jahresergebnisse einer prospektiven, randomisierten Therapiestudie im Auftrag des DÖSAK. Mund Kiefer GesichtsChir 18: 5-12
21. Pignon JP, Bourhis J, Domenge C, Désigné L on behalf of the MACH-NC collaborative group (2000) Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: Three meta-analyses of updated individual data. Lancet 355: 949-955 10768432
22. Rübe C, Hampel G, Schuck A, Willich N (1996) Kombinationswirkung von Paclitaxel und ionisierender Strahlung. Experimentelle Daten aus In-vitro- und In-vivo-Modellen. Strahlenther Onkol 172 (Suppl I): 1-5 8571181
23. Schroeder M, Makoski HB, Sesterhenn K, Schröder R, Westerhausen M (1998) Hohe Remissionsraten unter simultaner Radio- und Chemotherapie mit Paclitaxel/5-FU in der Behandlung fortgeschrittener Kopf-Hals-Tumoren. Strahlenther Onkol 174 (Suppl I): 6-8 9879340
24. Suntharalingam M, Haas ML, Conley BA et al. (2000) The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys 47: 49-56 10.1016/S0360-3016(00)00408-9
25. Suntharalingam M, Haas ML, Van Echo DA, Haddad R, Jacobs MC, Levy S, Gray WC, Ord RA, Conley BA (2001) Predictors of response and survival after concurrent chemotherapy and radiation for locally advanced squamous cell carcinomas of the head and neck. Cancer 91: 548-554 10.1002/1097-0142(20010201)91:3<548::AID-CNCR1033>3.0.CO;2-A
26. Sunwoo JB, Herscher LL, Kroog GS et al. (2001) Concurrent paclitaxel and radiation in the treatment of locally advanced head and neck cancer. J Clin Oncol 19: 800-811 11157034
27. Wanebo HJ, Chougule P, Akerley W et al. (1997) Preoperative paclitaxel, carboplatin and radiation in advanced head and neck cancer (stage III and IV) induces a high rate of complete pathologic response (CR) at the primary site and high rate of organ preservation. Proc Am Soc Clin Oncol 16: 391
28. Wanebo HJ, Chougule P, Ready N et al. (1999) Preoperative paclitaxel, carboplatin and radiation therapy in advanced head and neck cancer (stage III and IV). Sem Radiat Oncol 9 (Suppl 1): 77-84
29. Wendt TG (1996) Radio-Chemo-Therapie bei fortgeschrittenen Kopf-Hals-Karzinomen - was ist gesichert? Strahlenther Onkol 172: 409-416 8765342
30. Zamboglou N, Schnabel T, Kolotas C et al. (1994) Carboplatin and radiotherapy in the treatment of head and neck cancer: Six years' experience. Semin Oncol 21 (Suppl 12): 45-53 7992066